Amalgamated Bank Denali Therapeutics Inc. Transaction History

Amalgamated Bank

$13.6 Billion
Q3 2025

A detailed history of Amalgamated Bank transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Amalgamated Bank holds 4,305 shares of DNLI stock, worth $75,079. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,305

Previous 4,305 -0.0%

Holding current value

$75,079

Previous $60,000 3.33%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	BUY	$13.6 - $23.59 $1,536 - $2,665	113 Added 2.7%	4,305 $59,000
Q2 2024 Aug 12, 2024	BUY	$14.96 - $23.22 $2,513 - $3,900	168 Added 4.17%	4,192 $97,000
Q1 2024 Apr 23, 2024	SELL	$15.83 - $23.35 $206,312 - $304,320	-13,033 Reduced 76.41%	4,024 $83,000
Q4 2023 Feb 06, 2024	SELL	$16.2 - $23.18 $19,407 - $27,769	-1,198 Reduced 6.56%	17,057 $366,000
Q3 2023 Nov 08, 2023	BUY	$20.63 - $30.17 $14,007 - $20,485	679 Added 3.86%	18,255 $377,000
Q2 2023 Aug 11, 2023	BUY	$23.37 - $32.96 $51,320 - $72,380	2,196 Added 14.28%	17,576 $518,000
Q1 2023 May 02, 2023	SELL	$21.91 - $32.67 $56,505 - $84,255	-2,579 Reduced 14.36%	15,380 $354,000
Q4 2022 Feb 10, 2023	BUY	$26.28 - $33.92 $53,006 - $68,416	2,017 Added 12.65%	17,959 $499,000
Q3 2022 Nov 09, 2022	BUY	$25.97 - $38.53 $9,868 - $14,641	380 Added 2.44%	15,942 $489,000
Q2 2022 Aug 15, 2022	BUY	$20.88 - $35.19 $13,968 - $23,542	669 Added 4.49%	15,562 $458,000
Q1 2022 Jun 30, 2022	SELL	$29.0 - $47.27 $32,451 - $52,895	-1,119 Reduced 6.99%	14,893 $479,000
Q4 2021 Feb 15, 2022	SELL	$42.59 - $55.02 $7,325 - $9,463	-172 Reduced 1.06%	16,012 $714,000
Q3 2021 Oct 29, 2021	SELL	$48.48 - $78.23 $48,334 - $77,995	-997 Reduced 5.8%	16,184 $816,000
Q2 2021 Aug 16, 2021	BUY	$50.3 - $78.44 $413,868 - $645,404	8,228 Added 91.9%	17,181 $1.35 Million
Q1 2021 May 13, 2021	SELL	$53.8 - $81.53 $47,075 - $71,338	-875 Reduced 8.9%	8,953 $511,000
Q4 2020 Feb 12, 2021	BUY	$36.89 - $93.56 $1,807 - $4,584	49 Added 0.5%	9,828 $823,000
Q3 2020 Oct 30, 2020	SELL	$23.13 - $38.84 $6,592 - $11,069	-285 Reduced 2.83%	9,779 $350,000
Q2 2020 Aug 10, 2020	BUY	$16.01 - $28.82 $161,124 - $290,044	10,064 New	10,064 $243,000

Others Institutions Holding DNLI

# of Institutions

263

Shares Held

128M

Call Options Held

227K

Put Options Held

122K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.34B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Denali Therapeutics Inc. Transaction History